CD8A and neoplasm: Metadherin (MTDH) is expressed in a variety of malignancies (Hu et al., 2009; Yang et al., 2017), and treatment with Mtdh-ASO increases CD8+ T cells and enhances tumor immunity (Wan et al., 2022).